The investments come amid an ongoing investment fraud probe into AstraZeneca’s former China head Leon Wang—and despite ...

Tallying up a wide range of investments, AstraZeneca said it is pumping $2.5 billion into Beijing. The figure includes ...

The tech-heavy Nasdaq Composite index recently entered correction territory. Though it was able to climb out of it, equities ...

AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...

HONG KONG, LONDON] Ever since AstraZeneca shocked investors in October with news its China chief was under investigation, the ...

Leon Wang, the president of AstraZeneca’s China division, was last year detained alongside several other employees amid an investigation into operations in the country. Authorities are looking ...

British pharmaceutical giant AstraZeneca on Friday announced plans to invest $2.5 billion in China, despite the detention ...

BEIJING] AstraZeneca will invest US$2.5 billion in a new research centre in Beijing, in a major show of commitment to China ...

AstraZeneca (AZN) said Friday it plans to invest $2.5 billion in a new research and development hub in China as the drugmaker tries to reignite ...

The largest of the collaborations is a potentially more than $4.68 billion partnership with Shanghai-based Harbour BioMed to ...

LONDON, March 21 (Reuters) - AstraZeneca (AZN.L), opens new tab ... The company put its former China head Leon Wang, who also led its international business as an executive vice president, on ...

AstraZeneca's shares fell off a cliff late last year when it announced the arrest of some of its executives in China, including Leon Wang, the drugmaker's president in the country. That's on top ...